24 April 2018 | News
The BioMedTech Horizons program is providing the necessary support to boost investment, commercialisation and success of health innovations in Australia.
Image credit- engadget.com
MTPConnect and the Minister for Health, the Hon Greg Hunt MP, recently announced that Indee Labs will be receiving grant funding of nearly A$1 million from the Australian Government's A$35 million BioMedTech Horizons program to advance their gene therapy manufacturing technology.
Indee Labs' project will develop a product based on the mechanical phenomenon of microfluidic vortex shedding (µVS) into an end product that will be trialed by pharmaceutical companies worldwide. Collaborators on the project include; Australian National Nanofabrication Facility South Australian Node (ANFF-SA), Future Industries Institute, University of South Australia; Defence Science Technologies Group; University of Sydney.
The BioMedTech Horizons program is providing the necessary support to boost investment, commercialisation and success of health innovations in Australia. The program is being delivered as a part of the Australian Government's $20 billion Medical Research Future Fund, which aims to transform health and medical research to improve lives, build the economy and contribute to health system sustainability through targeted strategic investment.